Product Description
Mechanisms of Action: COMT Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Algeria | Argentina | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Chile | China | Colombia | Croatia | Cyprus | Czech | Dominican Republic | Ecuador | Egypt | Estonia | France | Germany | Greece | Hong Kong | Hungary | India | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | Spain | Sri Lanka | Switzerland | Taiwan | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | Uruguay | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: ALIO MEDICA Sp. z o.o.
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 4: Venous Thrombosis|Postthrombotic Syndrome|Postphlebitic Syndrome|Venous Insufficiency|Pelvic Pain|Forearm Injuries|Rectal Fistula|Chronic Pain|Edema|Anal Fistula|Varicose Veins|Lymphedema
Phase 3: Infertility|Peptic Ulcer|Ovarian Hyperstimulation Syndrome|Chronic Pain|Kidney Diseases|Common Bile Duct Diseases|Uterine Diseases|Ovarian Diseases|Venous Insufficiency|Hypertension, Renal|Pelvic Pain|Edema|Abdominal Pain|Varicose Veins|Depressive Disorder|Leukocyte Disorders|Inflammation|Bile Reflux|Vaginal Diseases|Cellulite|Lipodystrophy|Non-alcoholic Steatohepatitis|Hemorrhoids|Colitis, Ulcerative|Hepatitis, Alcoholic|Arthritis, Rheumatoid|Fatty Liver, Alcoholic
Phase 1: Coronavirus Infections|Acute Respiratory Distress Syndrome
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| RyazanSMU | N/A |
Active, not recruiting |
Edema|Varicose Veins |
2026-04-01 |
|
| N202309013 | P4 |
Recruiting |
Rectal Fistula|Anal Fistula |
2025-12-31 |
|
| NCT05756179 | P3 |
Recruiting |
Arthritis, Rheumatoid |
2025-09-01 |
|
| PVDUS-01 | N/A |
Not yet recruiting |
Scleroderma, General|Scleroderma, Diffuse|Scleroderma, Systemic|Skin Ulcer |
2025-07-15 |